Abstract:Nucleotide excision repair (NER) is the only mechanism in humans to repair UV-induced DNA lesions such as pyrimidine (6-4) pyrimidone photoproducts and cyclobutane pyrimidine dimers (CPDs). In response to UV damage, the ataxia telangiectasia mutated and Rad3-related (ATR) kinase phosphorylates and activates several downstream effector proteins, such as p53 and XPA, to arrest cell cycle progression, stimulate DNA repair, or initiate apoptosis. However, following the completion of DNA repair, there must be active mechanisms that restore the cell to a prestressed homeostatic state. An important part of this recovery must include a process to reduce p53 and NER activity as well as to remove repair protein complexes from the DNA damage sites. Since activation of the damage response occurs in part through phosphorylation, phosphatases are obvious candidates as homeostatic regulators of the DNA damage and repair responses. Therefore, we investigated whether the serine/threonine wild-type p53-induced phosphatase 1 (WIP1/PPM1D) might regulate NER. WIP1 overexpression inhibits the kinetics of NER and CPD repair, whereas WIP1 depletion enhances NER kinetics and CPD repair. This NER suppression is dependent on WIP1 phosphatase activity, as phosphatase-dead WIP1 mutants failed to inhibit NER. Moreover, WIP1 suppresses the kinetics of UV-induced damage repair largely through effects on NER, as XPD-deficient cells are not further suppressed in repairing UV damage by overexpressed WIP1. Wip1 null mice quickly repair their CPD and undergo less UV-induced apoptosis than their wild-type counterparts. In vitro phosphatase assays identify XPA and XPC as two potential WIP1 targets in the NER pathway. Thus WIP1 may suppress NER kinetics by dephosphorylating and inactivating XPA and XPC and other NER proteins and regulators after UV-induced DNA damage is repaired.

The type 2C phosphatase Wip1: An oncogenic regulator of tumor suppressor and DNA damage response pathways

The Wip1 Phosphatase and Mdm2: Cracking the "wip" on P53 Stability.

The Wip1 Phosphatase And Mdm2: Cracking The "Wip" On P53 Sta

Advance in the Research of Serine/threonine Phosphatase Wip1

The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop.

The Oncogenic Phosphatase WIP1 Negatively Regulates Nucleotide Excision Repair

Cancer esearch cular and Cellular Pathobiology ogenic Wip 1 Phosphatase Is Inhibited by miR-16 R e DNA Damage Signaling Pathway

Phosphatase Wip1 in Immunity: an Overview and Update

Reversal of the ATM/ATR-mediated DNA Damage Response by the Oncogenic Phosphatase PPM1D.

The Biological Function and the Regulatory Roles of Wild-Type P53-Induced Phosphatase 1 in Immune System

Wild-type P53-Induced Phosphatase 1 Dephosphorylates Histone Variant Γ-H2ax and Suppresses DNA Double Strand Break Repair

Wip1 suppresses ovarian cancer metastasis through the ATM/AKT/Snail mediated signaling.

The role of PPM1D in cancer and advances in studies of its inhibitors

The role of low-molecular-weight protein tyrosine phosphatase (LMW-PTP ACP1) in oncogenesis

Dephosphorylation of γ-H2AX by WIP1: An important homeostatic regulatory event in DNA repair and cell cycle control

Association Between Overexpression of Wip1 and Prognosis of Patients with Non-Small Cell Lung Cancer.

Overexpression Of Wip1 Is Associated With Biologic Behavior In Human Clear Cell Renal Cell Carcinoma

Inhibition of the DNA damage response phosphatase PPM1D reprograms neutrophils to enhance anti-tumor immune responses

Abstract C030: The Wip1 phosphatase activator QGC-8-52 selectively sensitizes p53-deficient cancer cells to chemotherapy

Wip1 cooperates with KPNA2 to modulate the cell proliferation and migration of colorectal cancer via a p53‐dependent manner

Medulloblastomas Overexpress the P53-Inactivating Oncogene WIP1/PPM1D